OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
STXS
Stereotaxis, Inc.
Common Stock
710 North Tucker Boulevard
Suite 110
St. Louis, MO 63101
Business Description
Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001289340
Fiscal Year End
12/31
Company Officers & Contacts
David Fischel
CEO
Martin C. Stammer
CFO, IR
Karen Duros
General Counsel
Board of Directors
David Fischel
Chairman, CEO
David W. Benfer
Independent Director, Nominating Committee Member
Joseph Kiani
Ross B. Levin
Audit Committee Member
Arun Menawat
Robert J Messey
Independent Director, Audit Committee Member, Compensation Committee Member
Other Company Insiders
Not available
Service Providers
Accounting/Auditing Firm
Ernst & Young LLP5 Times Square
New York, NY 10036-6530
Profile Data
SIC - Industry Classification
3845 - Electromedical equipment
Incorporation Information
DE, US, 1990
Employees
122 as of 07/22/2016
Shell
No
Products and Services
Not available
Company Facilities
Not available
Company Notes
Sponsored for OTCQX by Bryan Cave LLP on 8/4/2016.
Loading...
Symbol
OTCM
Last
57.41
Change
0.41 (0.72%)
Bid
57.40
Ask
58.40
Volume
667
Time
00:00
